Navigation Links
Cellular Biomedicine Group Provides Update and 2013 Milestones
Date:4/25/2013

of Osteoarthritis and a patent for using allogeneic stromal vascular fraction and haMPCs or mesenchymal progenitor cells for the prevention and treatment of Rheumatoid Arthritis.

Key milestones that CBMG aims to accomplish in 2013 include:

  • Approval of a Stromal Vascular Fraction (SVF) kit by the SFDA. SVF kits are 'toolboxes' used by physicians to safely extract cell samples from patients.
  • Adipose tissue transportation kit approval as a medical device. These kits permit safe and effective transportation of extracted or processed cells. 
  • Completion of KOA Phase I trial safety data and advanced staggered filing of Phase II trial.
  • Preliminary HCC Phase I trial results.
  • Approval of additional pending Patent Cooperation Treaty (PCT) patents.

"We look forward to many new developments in 2013," said Chairman and CEO Dr Steve Liu . "Not only are we the first company to pursue international compliance and set standards for two clinical pathways of cell therapies in China's emerging cellular medicine market, but we have the advantage of operating manufacturing facilities at the highest international standards, and joint ventures with international partners. We believe we are poised to become a leading translational cellular medicine platform in China, offering therapies to treat serious diseases prevalent in this region."

About Cellular Biomedicine Group

Cellular Biomedicine Group, Inc. develops proprietary cell therapies for the treatment of certain degenerative diseases and cancers.  Our developmental stem cell, progenitor cell, and immune cell projects are the result of research and development by scientists and doctors from China and the United States. Our flagship GMP facility, consisting of eight indepe
'/>"/>

SOURCE Cellular Biomedicine Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Cellular Dynamics Announces Commercial Launch of iCell® Neurons for Neuroscience Drug Discovery
2. Van Andel Research Institute Study Provides New Details of Fundamental Cellular Process
3. Proteins shine a brighter light on cellular processes
4. Childhood Obesity Linked to Increased Risk of Hepatocellular Carcinoma in Adulthood
5. EastBridge Investment Group Announces Completion of its Merger with Cellular Biomedicine Group - Shareholder Conference Call to be held February 8th
6. Cellular Therapy Market and Cord Blood Market 2013 Industry Research Report: MarketResearchReports.Biz
7. Cellular Biomedicine Group Announces ISO 9001:2008 Certification and ISO-14644 Cleanroom Certification
8. Cellular Biomedicine Group President Presents Keynote Address at New York Stem Cell Summit
9. Cellular Biomedicine Group Appoints Dr. Jianping Dai to the Board of Directors
10. Cellular Dynamics and Coriell Institute for Medical Research Awarded Multi-Million Dollar Grants from California Institute for Regenerative Medicine to Manufacture and Bank Stem Cell Lines
11. Cellular Therapy and Cord Blood 2013 Market Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 15, 2014 -- According to the International Atomic ... security comes from terrorists acquiring sufficient quantities of ... a crude nuclear explosive device. The IAEA also ... have involved gram-level quantities, which can be challenging ... to a new study appearing this week in ...
(Date:7/10/2014)... Understanding the basis of psychiatric disorders has been extremely ... increase risk but are insufficient to cause disease. Now ... Cell Press journal Cell Stem Cell describe ... genetic risks interact with other risk factors or environmental ... Their research pinpoints a genetic variant that may predispose ...
(Date:7/10/2014)... for crude 3-D glasses, polarized glasses, and shutter ... devices, used to trick the brain into perceiving ... obsolete with the introduction of new holography technology ... doctoral students Yuval Yifat, Michal Eitan, and Zeev ... nanoantennas that could be used for security as ...
(Date:1/15/2014)... the device," Nobel laureate Herbert Kroemer famously observed, ... at the junctures where layers of different materials ... interfaces between layers of metal oxides are becoming ... as spintronics, high-temperature superconductors, ferroelectrics and multiferroics. Realizing ...
Breaking Biology Technology:Sensitive detection method may help impede illicit nuclear trafficking 2New strategy could uncover genes at the root of psychiatric illnesses 2Projecting a 3-dimensional future 2Projecting a 3-dimensional future 3A deeper look at interfaces 2
... Holdings, Inc. (NYSE: ZMH ; SIX: ... introduced two new consulting service programs designed to ... the delivery of orthopaedic care.  Offered through Zimmer,s ... Advantage and Practice Advantage programs are designed to ...
... N.J., Feb. 16, 2011 Amicus Therapeutics (Nasdaq: ... from the ongoing Phase 2 extension study of its ... be presented at the Lysosomal Disease Network WORLD Symposium ... the Company announced that it will present encouraging data ...
... Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR ) today ... to the S&P SmallCap 600 Index effective after the close ... "Our inclusion in the S&P SmallCap 600 Index ... our visibility within the investment community as we continue our ...
Cached Biology Technology:Zimmer Helps Physicians and Hospitals Negotiate Emerging Health Care Business Challenges Through New Consulting Programs 2Zimmer Helps Physicians and Hospitals Negotiate Emerging Health Care Business Challenges Through New Consulting Programs 3Zimmer Helps Physicians and Hospitals Negotiate Emerging Health Care Business Challenges Through New Consulting Programs 4Amicus Therapeutics Provides Positive Data Update from Phase 2 Long-Term Extension Study of Amigal™ for Fabry Disease 2Amicus Therapeutics Provides Positive Data Update from Phase 2 Long-Term Extension Study of Amigal™ for Fabry Disease 3Amicus Therapeutics Provides Positive Data Update from Phase 2 Long-Term Extension Study of Amigal™ for Fabry Disease 4Amicus Therapeutics Provides Positive Data Update from Phase 2 Long-Term Extension Study of Amigal™ for Fabry Disease 5Amicus Therapeutics Provides Positive Data Update from Phase 2 Long-Term Extension Study of Amigal™ for Fabry Disease 6Questcor Pharmaceuticals to Be Added to S&P SmallCap 600 Index 2
(Date:7/10/2014)... cities in New Mexico, nearly every public golf course ... precious potable water supplies. Across the U.S. Southwest as ... receive treated effluent. Reusing the effluent increases the sustainability ... homeowners alike fertilize their lawns during the growing season. ... Mexico State University turfgrass expert has a new vision ...
(Date:7/10/2014)... 2014  The American Academy of Forensic Sciences ... and Technology (NIST) and the Department of Justice ... forensic science expert members to the Forensic Science ... of the NIST,s Organization of Scientific Area Committees ... appointments made to the new FSSB that has ...
(Date:7/10/2014)... NEW YORK , June 27, 2014 /PRNewswire/ ... against Provectus Biopharmaceuticals, Inc. ("Provectus" or the "Company")(NYSE-MKT: ... action, filed in United States District Court, Middle ... Division, is on behalf of a class consisting ... otherwise acquired Provectus securities between December 17, 2013 ...
Breaking Biology News(10 mins):'Tailored' water -- the latest in lawn care 2Ten Members of the American Academy of Forensic Sciences Appointed to Forensic Science Standards Board (FSSB) 2Ten Members of the American Academy of Forensic Sciences Appointed to Forensic Science Standards Board (FSSB) 3SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 3
... taken a significant step in controlling chemical reactions mechanically, ... Zocchi and colleagues report. Chemical reactions ... protein molecules that speed up reactions. Each protein catalyzes ... collide and exchange atoms; the enzyme is the third ...
... international scientists will meet at a conference in ... of plant membranes, an understanding of which is crucial to ... "Agriculture today is tough. According to a recent UN ... next 50 years than we have in the last 10,000, ...
... September 16, 2010 Menachem Shoham, PhD, associate professor ... Case Western Reserve University School of Medicine, has identified ... Methicillin Resistant Staphylococcus Aureus (MRSA) harmless by preventing the ... of MRSA are a growing public health problem causing ...
Cached Biology News:UCLA physicists control chemical reactions mechanically 2UCLA physicists control chemical reactions mechanically 3World conference on biology behind food security 2Case Western Reserve researcher discovers new 'anti-pathogenic' drugs to treat MRSA 2
Bovine Serum Albumin Heat Shock Diagnostic Grade Powder...
MpV17 transgene, murine homolog, glomerulosclerosis...
... the premium quality siRNAs you need for ... be readily ordered online by providing either ... providing the sense and antisense siRNA sequences. ... Silencer Pre-designed siRNAs, which are already designed ...
Human SDNSF/MCFD2 Biotinylated Affinity Purified PAb...
Biology Products: